PARTNER 3 at 5 Years: Low-Risk Patients and TAVI… Quo Vadimus?
Five-year results from the PARTNER 3 trial, which evaluated the balloon-expandable SAPIEN 3® TAVI versus surgical aortic valve replacement (SAVR) in low-risk patients.
Mortality and Cost of Cardiac Stimulation Device Infections According to the Applied Treatment: Expert Commentary
Dr. Encarnación Gutiérrez’s review discusses the current state of managing infections associated with cardiac stimulation devices (CSDs), addressing the increase in associated costs due to three primary factors.
Rapid Growth in Thoracic Aortic Aneurysms: A Reliable Surgical Criterion?
A retrospective study conducted by Yale University over three decades scrutinizes the data from its Aortic Institute to assess the validity of surgical indications for rapid growth exceeding 3 mm/year.
Heparin-Induced Thrombocytopenia Following Cardiac Surgery: What Is the Real Impact?
A retrospective study conducted in the United States analyzed the incidence, outcomes, and costs associated with heparin-induced thrombocytopenia (HIT) in patients undergoing cardiac surgery.
Frozen Elephant Trunk with Thromboembolic Complications: Are There Peculiarities in the Rate and Pattern of Complications?
This retrospective study evaluates the frequency and clinical impact of thromboembolic complications following aortic arch repair utilizing the Frozen Elephant Trunk (FET) with the Thoraflex® device (Terumo Aortic®).
Long-term use of ventricular assist devices in children: Is it feasible and safe?
This study, conducted at a tertiary pediatric cardiology center, evaluates the long-term use of ventricular assist devices (VADs).
Are leadless pacemakers a safe alternative following cardiac surgery or percutaneous valve interventions?
This single-center retrospective study analyzes the clinical and safety outcomes of leadless pacemakers in patients requiring permanent pacing after cardiac surgery or transcatheter valve intervention.
Mitral valve replacement in pediatrics: size matters greatly. The expert’s perspective.
Update on the status of mitral valve replacement in pediatric patients, by expert Dr. María Luz Polo.
